Home  >  The Inquiry  >  Have we reached a turning point with migraine medication?
The Inquiry
Have we reached a turning point with migraine medication?
The Inquiry
Nov 30, 2023

Around 1 billion people around the world suffer from a mysterious neurological condition called migraine. Far more than just a headache, migraine is abnormal processing of the world around us that can have symptoms like loss of sight and speech, dizziness, nausea and extreme fatigue.

There are drugs which can help those struggling with the condition like anti-depressants and anti-convulsants. However, they weren’t developed specifically for migraine and can come with quite a lot of side effects or simply not work.

For a long time migraine medication has been a process of trial and error.

But a new class of drugs called anti-CGRPs are being hailed as a breakthrough migraine medication. Anti-CGRPs have a small side effect profile and were designed specifically to target migraine. They work by blocking CGRP (Calcitonin Gene-Related Peptide) from building up in the body and triggering a receptor in the brain which turns on a head pain pathway causing the migraine attack.

Earlier this year the National Institute of Health and Care Excellence - or NICE – in England cleared the use of an anti-CGRP called Rimegepant to use as both a preventive and acute treatment. Clinicians are hoping this will massively improve the lives of those living with the condition.

So this week on The Inquiry were asking ‘Have we reached a turning point with migraine medication?’

Contributors: Dr. Amaal Starling, neurologist and headache specialist at Mayo Clinic in Scottsdale, in the US state of Arizona. Dr Faraidoon, researcher at the Georgian Institute for Global Health at the University of New South Wales, Sydney, Australia. Peter Goadsby , Director of the NIHR King's Clinical Research Facility and a professor of neurology at King's College London, England. Dr Lise Rystad Oie, researcher at the government funded Norwegian Centre for Headache Research - also known as NorHead.

Presenter: Charmaine Cozier Producer: Anoushka Mutanda-Dougherty Editor: Tara McDermott Researcher: Matt Toulson Technical Producer: Craig Boardman Broadcast Co-ordinator: Jordan King

Image: eternalcreative - Getty Images: 1372323487

More Episodes
Apr 7, 2026
Is it time to scrap the Commonwealth Games?

For the second time in 12 years Glasgow is preparing to host the Commonwealth Games after Australia’s Victoria state pulled out because of increased costs. Victoria’s withdrawal raised questions about whether the 2026 games would go ahead before Glasgow agreed to step in.

Staging a sporting mega-event is expensive and governments face increasing scrutiny over public spending. Victoria’s decision raised wider questions about affordability for potential hosts. At the same time, critics question the Games’ political relevance, given its origins in Britain’s colonial past.

The Commonwealth Games Federation says the event can be delivered in a more sustainable way and argues that it brings cultural and economic benefits to host cities, but recent editions have run into significant costs and budget pressures.

This week on The Inquiry, Tanya Beckett asks ‘Is it time to scrap the Commonwealth Games?’

Contributors: Dr Stuart Whigham, senior lecturer in sport, coaching and physical education at Oxford Brookes University, UK Dr Matthew McDowell, lecturer in sport policy, management, and international development at the University of Edinburgh, UK Dr Verity Postlethwaite, lecturer in strategic event management at Loughborough University, UK Professor Gayle McPherson, associate dean for research at the University of the West of Scotland, and director of legacy and community engagement for Commonwealth Games Scotland, UK

Presenter: Tanya Beckett Producer: Matt Toulson Researcher: Evie Yabsley Editor: Tom Bigwood Technical Producer: Craig Boardman Production Management: Phoebe Lomas and Liam Morrey

(Photo: 2022 Commonwealth Games gold medals. Credit: Adrian Dennis/Getty Images)


23min 58sec




Have we reached a turning point with migraine medication?

--:--
--:--